title: No circadian variation of dihydropyrimidine dehydrogenase, uridine phosphorylase, beta-alanine, and 5-fluorouracil during continuous infusion of 5-fluorouracil.
authors.affiliation: Department Clinical Chemistry, Academic Medical Center, University of Amsterdam, The Netherlands.
authors.forename: A B
authors.initials: AB
authors.lastname: Van Kuilenburg
authors.forename: R L
authors.initials: RL
authors.lastname: Poorter
authors.forename: G J
authors.initials: GJ
authors.lastname: Peters
authors.forename: A H
authors.initials: AH
authors.lastname: Van Gennip
authors.forename: H
authors.initials: H
authors.lastname: Van Lenthe
authors.forename: A E
authors.initials: AE
authors.lastname: Stroomer
authors.forename: K
authors.initials: K
authors.lastname: Smid
authors.forename: P
authors.initials: P
authors.lastname: Noordhuis
authors.forename: P J
authors.initials: PJ
authors.lastname: Bakker
authors.forename: C H
authors.initials: CH
authors.lastname: Veenhof
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D002940:Circadian Rhythm; D015179:Colorectal Neoplasms / Q000097:blood / Q000188:drug therapy*; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007963:Leukocytes, Mononuclear / Q000201:enzymology*; D010088:Oxidoreductases / Q000097:blood*; D012044:Regression Analysis; D014543:Uridine Phosphorylase / Q000097:blood*; D015091:beta-Alanine / Q000097:blood*
chemical_list: D000964:Antimetabolites, Antineoplastic; D015091:beta-Alanine; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D014543:Uridine Phosphorylase; D005472:Fluorouracil